| scholarly article | Q13442814 |
| P50 | author | Jean-Pierre Montani | Q80061669 |
| João M Carvas | Q84510310 | ||
| Gautham Yepuri | Q60314125 | ||
| P2093 | author name string | Brenda R Kwak | |
| Zhihong Yang | |||
| Jianhui Li | |||
| Xiu-Fen Ming | |||
| Yuyan Xiong | |||
| Zongsong Wu | |||
| Claudio Sartori | |||
| Urs Scherrer | |||
| Isabelle Scerri | |||
| Angana G Rajapakse | |||
| Jean Ruffieux | |||
| Katja Popp | |||
| P2860 | cites work | Inflammation and lung cancer: roles of reactive oxygen/nitrogen species | Q23918826 |
| Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance | Q24617743 | ||
| Purification of rat kidney arginases A1 and A4 and their subcellular distribution | Q70439552 | ||
| Exploring the full spectrum of macrophage activation | Q24653754 | ||
| Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
| A role for mitochondria in NLRP3 inflammasome activation | Q28131794 | ||
| Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells | Q28509783 | ||
| Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome | Q29547419 | ||
| Monocyte and macrophage heterogeneity | Q29547438 | ||
| The chemokine system in diverse forms of macrophage activation and polarization | Q29547719 | ||
| Macrophages, inflammation, and insulin resistance | Q29614351 | ||
| Nitric oxide and the immune response | Q29617591 | ||
| Cutting edge: Stat6-dependent substrate depletion regulates nitric oxide production | Q31838783 | ||
| Age-related alteration of arginase activity impacts on severity of leishmaniasis | Q33334323 | ||
| The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages | Q33525044 | ||
| Macrophage plasticity in experimental atherosclerosis | Q33527405 | ||
| Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity | Q33930230 | ||
| Arginase in glomerulonephritis | Q34114529 | ||
| Pathophysiology of coronary artery disease | Q34429470 | ||
| Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells | Q34443037 | ||
| Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens | Q34657537 | ||
| Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS) | Q34681297 | ||
| Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata | Q35251005 | ||
| Macrophage diversity in renal injury and repair. | Q36955562 | ||
| Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals | Q37072370 | ||
| Arginase in parasitic infections: macrophage activation, immunosuppression, and intracellular signals | Q37474041 | ||
| Oxidative stress and mitochondrial dysfunction in atherosclerosis: mitochondria-targeted antioxidants as potential therapy. | Q37630642 | ||
| Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis | Q37698287 | ||
| Generation of a mouse model for arginase II deficiency by targeted disruption of the arginase II gene | Q39457714 | ||
| The arginase II gene is an anti-inflammatory target of liver X receptor in macrophages | Q40237860 | ||
| Connexin37 protects against atherosclerosis by regulating monocyte adhesion | Q40252212 | ||
| Arginase I: a limiting factor for nitric oxide and polyamine synthesis by activated macrophages? | Q40842250 | ||
| Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells | Q40928270 | ||
| Induction of intracellular arginase activity does not diminish the capacity of macrophages to produce nitric oxide in vitro. | Q40940347 | ||
| Differential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells. | Q40994843 | ||
| Comparative properties of arginases | Q41076476 | ||
| Opposing and uncoupling effects of mTOR and S6K1 in the regulation of endothelial tissue factor expression. | Q43242140 | ||
| Differential Regulation of Nitric Oxide Synthase-2 and Arginase-1 by Type 1/Type 2 Cytokines In Vivo: Granulomatous Pathology Is Shaped by the Pattern ofl-Arginine Metabolism | Q43803694 | ||
| Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo. | Q46423511 | ||
| Endothelial arginase II: a novel target for the treatment of atherosclerosis | Q46726767 | ||
| Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype | Q48032440 | ||
| A novel nervous system-induced factor inducing immune responses in the spleen | Q48073136 | ||
| Vulnerable atherosclerotic plaque metalloproteinases and foam cell phenotypes. | Q55605575 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 4 | |
| P921 | main subject | inflammation | Q101991 |
| macrophage | Q184204 | ||
| reactive oxygen species | Q424361 | ||
| insulin resistance | Q1053470 | ||
| P304 | page(s) | e000992 | |
| P577 | publication date | 2012-08-24 | |
| P1433 | published in | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | Q19880670 |
| P1476 | title | Arginase II Promotes Macrophage Inflammatory Responses Through Mitochondrial Reactive Oxygen Species, Contributing to Insulin Resistance and Atherogenesis | |
| P478 | volume | 1 |
| Q35852802 | ARG2 impairs endothelial autophagy through regulation of MTOR and PRKAA/AMPK signaling in advanced atherosclerosis |
| Q49389224 | Arginase II inhibition prevents interleukin-8 production through regulation of p38 MAPK phosphorylation activated by loss of mitochondrial membrane potential in nLDL-stimulated hAoSMCs. |
| Q42906216 | Arginase II: Atherogenesis Beyond Enzyme Activity |
| Q91635376 | Arginase Pathway in Acute Retina and Brain Injury: Therapeutic Opportunities and Unexplored Avenues |
| Q36854784 | Arginase Promotes Skeletal Muscle Arteriolar Endothelial Dysfunction in Diabetic Rats |
| Q26991946 | Arginase as a Critical Prooxidant Mediator in the Binomial Endothelial Dysfunction-Atherosclerosis |
| Q36033820 | Arginase inhibition attenuates arteriogenesis and interferes with M2 macrophage accumulation |
| Q34730537 | Arginase inhibition augments nitric oxide production and facilitates left ventricular systolic function in doxorubicin-induced cardiomyopathy in mice |
| Q37198831 | Arginase inhibition mediates renal tissue protection in diabetic nephropathy by a nitric oxide synthase 3-dependent mechanism |
| Q53691008 | Arginase inhibition prevents the development of hypertension and improves insulin resistance in obese rats. |
| Q36268285 | Arginase-I enhances vascular endothelial inflammation and senescence through eNOS-uncoupling |
| Q41699705 | Arginase-II Deficiency Extends Lifespan in Mice |
| Q52714758 | Arginase-II negatively regulates renal aquaporin-2 and water reabsorption. |
| Q36920831 | Arginase: The Emerging Therapeutic Target for Vascular Oxidative Stress and Inflammation |
| Q37310506 | Arginase‐II Induces Vascular Smooth Muscle Cell Senescence and Apoptosis Through p66Shc and p53 Independently of Its l ‐Arginine Ureahydrolase Activity: Implications for Atherosclerotic Plaque Vulnerability |
| Q53798961 | Asymmetric dimethylarginine (ADMA) elevation and arginase up-regulation contribute to endothelial dysfunction related to insulin resistance in rats and morbidly obese humans |
| Q51735384 | Deficient Arginase II Expression without Alteration in Arginase I Expression Attenuated Experimental Autoimmune Encephalomyelitis in Mice |
| Q55476883 | Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis |
| Q34406933 | Functions of arginase isoforms in macrophage inflammatory responses: impact on cardiovascular diseases and metabolic disorders |
| Q37428427 | Genetic Targeting of Arginase-II in Mouse Prevents Renal Oxidative Stress and Inflammation in Diet-Induced Obesity |
| Q51664532 | Genomics of human fatty liver disease reveal mechanistically linked lipid droplet-associated gene regulations in bland steatosis and nonalcoholic steatohepatitis |
| Q64067708 | Hepatic arginase 2 (Arg2) is sufficient to convey the therapeutic metabolic effects of fasting |
| Q34052492 | Human papillomavirus e7 oncoprotein transgenic skin develops an enhanced inflammatory response to 2,4-dinitrochlorobenzene by an arginase-1-dependent mechanism |
| Q93047040 | Hypoxia Enhances Endothelial Intercellular Adhesion Molecule 1 Protein Level Through Upregulation of Arginase Type II and Mitochondrial Oxidative Stress |
| Q35078422 | Increased endothelial inflammation, sTie-2 and arginase activity in umbilical cords obtained from gestational diabetic mothers |
| Q47229467 | Increased levels of circulating arginase I in overweight compared to normal weight adolescents. |
| Q89598307 | Is the Arginase Pathway a Novel Therapeutic Avenue for Diabetic Retinopathy? |
| Q51747901 | Kidney Mass Reduction Leads to l-Arginine Metabolism-Dependent Blood Pressure Increase in Mice |
| Q34634938 | Label-free quantitative urinary proteomics identifies the arginase pathway as a new player in congenital obstructive nephropathy |
| Q33801191 | Long term exposure to L-arginine accelerates endothelial cell senescence through arginase-II and S6K1 signaling |
| Q50966253 | Long-term dietary restriction up-regulates activity and expression of renal arginase II in aging mice |
| Q92195093 | Mechanisms of obesity-induced metabolic and vascular dysfunctions |
| Q41990626 | Microbiota of Chronic Diabetic Wounds: Ecology, Impact, and Potential for Innovative Treatment Strategies |
| Q36815194 | Mincle-mediated translational regulation is required for strong nitric oxide production and inflammation resolution |
| Q38125279 | Molecular Biology of Atherosclerosis |
| Q38252544 | Molecular pathways of arterial aging |
| Q47734746 | Obesity-induced vascular dysfunction and arterial stiffening requires endothelial cell arginase 1. |
| Q39469302 | PKCη deficiency improves lipid metabolism and atherosclerosis in apolipoprotein E-deficient mice. |
| Q42725788 | Polarization of Macrophages toward M2 Phenotype Is Favored by Reduction in iPLA2β (Group VIA Phospholipase A2) |
| Q28396273 | Reactive oxygen species in inflammation and tissue injury |
| Q92095036 | Regulatory T cells use arginase 2 to enhance their metabolic fitness in tissues |
| Q64062113 | Role of Arginase 2 in Systemic Metabolic Activity and Adipose Tissue Fatty Acid Metabolism in Diet-Induced Obese Mice |
| Q36837617 | Role of Arginase in Vessel Wall Remodeling |
| Q90730101 | Role of Metabolites of Nitric Oxide and Arginase in the Pathogenesis of Glomerulonephritis |
| Q35149545 | Role of p38 mitogen-activated protein kinase in vascular endothelial aging: interaction with Arginase-II and S6K1 signaling pathway |
| Q36548517 | Targeting arginase-II protects mice from high-fat-diet-induced hepatic steatosis through suppression of macrophage inflammation |
| Q35576389 | p38 mitogen-activated protein kinase is involved in arginase-II-mediated eNOS-uncoupling in obesity |
Search more.